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Abstract
Infertility is a major public health concern in developing and developed 
nations. In certain societies, infertility carries a social stigma and is one of the 
key factors for breakup of families. The revolution created by assisted repro-
ductive technologies (AIR) in infertility treatment has given hope to childless 
couples to have children. The quality of diagnosis plays an important role in 
helping to deliver proper therapy to such couples. Therefore, judicious use of 
diagnostic tests and its interpretation play a vital role in infertility treatment. 
The presence of andrologists and gynecologists has helped to identify and guide 
the patient to take proper treatment for their childlessness. Hormonal assays, 
its interpretation followed by hormonal stimulation, retrieval of healthy fol-
licle, in vitro fertilization, implantation and growth of embryos require a team 
of experts to co-ordinate, advocate and advance the treatment to the patient. 
The promising field of stem cell therapy and storage banks of sperm, oocytes 
and embryos have opened new avenues of treatment and galvanized the field of 
reproduction. Therefore, books related to these aspects will help review, relate 
and redeem the field of infertility treatment. The ethical concerns of AIR will 
allow for introspection of the existing dilemmas and psychological concerns of 
the patient.
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1. Introduction
“Health is defined as a state of physical, mental and social well-being of an 
individual, not merely the absence of disease” (WHO) [1–3].
It includes reproductive health with an ability to have a fulfilling sexual life, 
an inherent capacity to procreate with a freedom to make choices of timing and 
planning child birth. It also provides the couple the freedom to seek treatment 
modalities for family planning as well for infertility.
Infertility is one of the major reproductive health problems that challenge the 
clinicians as well as the couples. Another domain of reproductive health is the 
culture of a couple who apart from longing to have children face social pressures to 
beget children. In certain cultures, it carries social stigma as well as forms the basis 
for divorce bringing in the legal as well as ethical issues. The psychological domain 
acts negatively on fertility potential of the couple [4].
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An added issue is gender bias and discrimination which falters the women as 
the major cause of infertility though science states that there are equal causes for 
infertility for both men and women [3].
2. Infertility
Infertility can be defined as the inability to conceive after one full year of regu-
lar, normal sexual intercourse without the use of any contraception. Infertility is a 
major health problem that affects a sizeable population in the world and the cause 
may be the male or female, with more or less 30–40% being due to the male factor 
or around 50% due to the female factor [5–7].
Oligospermia, poor semen quality, low sperm motility, anatomical defects 
like block in vas deferens, infections leading to inflammation of seminal vesicles, 
epididymis or prostate, genetic abnormalities like Klinefelter syndrome could 
represent major causes of male infertility [5–7].
Irregular ovulation, poor oocyte quality, blocked fallopian tubes due to infection 
or endometriosis are some of the causes of female infertility. Polycystic ovaries, 
primary and secondary amenorrhea, pelvic inflammatory disease (PID) and hostile 
cervical mucus may be less common causes of female infertility apart from cancer 
chemotherapy [6, 7].
2.1 Assisted methods of reproduction (ART)
35 years of assisted reproductive technology (ART) use has become one of the 
standard procedure of infertility treatment. More than 5 million babies are born 
after ART (1–5% births). Therefore, it is necessary to monitor, evaluate and trace 
the modifications of procedures with growing technical development of medical 
practice in the field of reproductive medicine [8].
Assisted reproduction techniques (ARTs) are defined as “all treatments or 
procedures that include the in vitro handling of both human oocytes and sperm or 
embryos for the purpose of establishing a pregnancy” [8].
2.2 Ovulation induction
Ovulation induction is useful in women with anovulatory or irregular ovulatory 
cycles. A hormone medication in tablet or injection form is administered to stimu-
late the production of follicle stimulating hormone (FSH). FSH then will help in the 
development of one or more follicles. Another hormone will then be administered 
to cause the release of ovum. The couples will be advised to have sexual intercourse 
during this period, creating a greater chance for conception [9].
2.3 Artificial insemination (AIH)
Artificial insemination (AIH) is also known as intrauterine insemination (IUI). 
AIH is recommended in cases of unknown etiology in women with healthy fallopian 
tubes or in men with erectile dysfunction or mechanical trauma which may hamper 
normal intercourse with the women. In certain cases before cancer chemotherapy or 
due to other reasons, semen stored in the sperm bank may be used for AIH [10].
2.4 In vitro fertilization (IVF)
In vitro fertilization (IVF) is a process in which ovum and sperm are allowed to 
fertilize in vitro. The process involves retrieval of ovum from the women and semen 
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from the male. If successful, the embryo is then implanted in the uterus of the 
woman using embryo transfer [11].
2.5 Gamete intra fallopian transfer (GIFT)
The ovum is retrieved from the woman and inserted between the layers of sperm 
and inserted into the fallopian tube. This allows natural fertilization. It is mostly 
used in conditions where religious beliefs do not permit IVF [11].
2.6 Intracytoplasmic sperm injection (ICSI)
Intracytoplasmic sperm injection (ICSI) is usually done in patients with 
oligospermia or with abnormal semen quality. It involves direct injection of single 
spermatozoa into the ovum to promote fertilization [12].
2.7 Zygote intrafallopian transfer (ZIFT)
Zygote intrafallopian transfer (ZIFT) involves the transfer of zygote [13].
2.8 Preimplantation genetic diagnosis (PGD)
Preimplantation genetic diagnosis (PGD) is useful in patients with a family his-
tory of genetic disorders. It may be recommended in couples with repeated miscar-
riages or failure in IVF or in elder patients say 35 years old or above [14].
Aneuploidy is a term used to describe an abnormality in chromosome number 
(fewer or more of a specific chromosome). Aneuploidy screening is performed in 
cases of advanced maternal age, repeated IVF failure, recurrent miscarriage and 
previous aneuploidy pregnancy [15].
2.9 In vitro maturation (IVM)
In vitro maturation of oocyte-cumulus complexes is a promising new technique 
by which immature oocytes from small follicles less than 10 mm are matured during 
30–40 h in a specific culture medium. Meta-phase II (M II) oocytes with normal 
morphology were inseminated by ICSI [16].
3. Making a correct diagnosis
The techniques involved in infertility diagnosis include ultrasound, computer-
ized tomography scan (CT-scan), nuclear magnetic resonance (NMR), hysteros-
copy, hysterosalpingography, laparoscopy, blood karyotyping histopathology of 
reproductive tissues, microbiology, serology and hormone analyses [17].
For males, standard semen analyses will be carried out to assess the sperm 
density, motility, fertilizing ability, and detection of anti-sperm antibodies.
Computerized analyses of semen (image analyses CASA) nowadays is used for 
semen analyses. Therefore, poor semen quality or primary or secondary causes 
of infertility (hormonal imbalance at the pituitary or at the target organ level or 
secondary hormonal causes like thyroid dysfunction) or even obesity will help 
determine and evaluate the patient for IVF or ICSI procedures [18, 19].
The treatment for infertility is judiciously adopted by the treating gynecologist 
at different levels by initially evaluating natural menstrual history of the patient 
followed by advising the couple to have sexual intercourse during the ovulatory 
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phase. If it fails, mild ovarian stimulation with hormones will be suggested and 
followed by sexual intercourse. The next level of treatment may be superovulation 
with hormonal stimulation and retrieval of oocytes for IVF. The extra embryos or 
oocytes are stored for future use [19, 20].
4. Oocyte donation
Oocyte donation is one of the necessary arms of ART. It is usually recommended 
for women with poor ovarian reserve possibly due to primary and secondary 
ovarian failure. It can be due to surgical causes, damage following chemotherapy 
or radiotherapy, with certain genetic disorders associated with gonadal dysgenesis 
like Turner syndrome or patient with a known genetic disorder. It is reported that 
oocyte donation is one of the most successful techniques resulting in pregnancy, 
particularly in perimenopausal women.
One of the earlier concerns was how to incorporate psychosocial care into the 
infertility treatment protocol. This incorporation of psychosocial care is to provide 
the best possible care to the infertile patient. After incorporating the psychosocial 
care into the treatment protocol, the patient’s preferences and needs are evaluated. 
The patient wishes to have good interaction with the staff; wishes continuity of 
care from the same doctor, get information that could be easily understood  by 
the patient and to have a long standing interaction with clinic and the healthcare 
personnel.
Singleton pregnancies, preterm delivery and perinatal mortality as well as 
maternal complications, such as preeclampsia, gestational diabetes, placenta previa, 
placental abruption and cesarean delivery are some of the reported outcomes of 
ART. The following figure (Figure 1) explains the possible factors that may influ-
ence pregnancy outcome following ART.
Cryopreservation of oocytes and embryos involves appreciating the multiple con-
texts in which oocyte and embryo cryopreservation may be applied. It will enable 
one to understand the relative impact of cryopreservation on oocytes and embryo 
quality. It will allow the reader to have a grasp of the concept of selection/attrition 
Figure 1. 
The factors that affect embryo/quality which determines the outcome of assisted reproductive methods.
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as it applies to the efficiency of assisted methods of reproduction (ART). It will 
allow to gain insights into relative balance of advantages and disadvantages associ-
ated with oocyte and embryo cryopreservation in different clinical conditions.
Apart from discussions on the nature of infertility and the assisted methods of 
reproduction, there are widespread discussions regarding the ethical aspects related 
to infertile patients and ART.
Sperm banks have become one of the accessory health centers of assisted reproduc-
tive technology. In simple terms, they collect viable healthy semen samples from 
responsible sperm donors and preserve them according to stipulated international 
standards. They become the dispensing center of semen to those needy couples 
or couples referred to them by the physician who treat these patients. Different 
countries have different rules and regulations depending upon the religion and 
sociocultural background. Taking one aspect of a complex issue of sperm donation 
like keeping the anonymity of sperm donor, many countries have different opinions 
or regulations. Some nations want anonymous sperm donors and in some countries 
it is suggested that names of sperm donors be made known. In India, sperm donation 
is common and yet it is a social taboo, rather a social paradox—one does not want to 
be seen in such clinics; yet many who are desperate to have a child in the family visit 
these banks. In countries like India, it is said, in desperation, the recipient’s father in 
law (husband’s father or brother) comes forward to donate semen samples. What will 
be the sociological implications to the child born out of such donation will be an ethi-
cal issue of great concern. It is said that sperm banks are facilitators receiving semen 
samples from the donors and giving the samples to the needy. This sounds very 
pragmatic and unethical. The name sperm bank itself like gene banks dehumanizes 
human life and dignity. Artificial insemination (“give life and give hope” sounds like 
“donate blood and save lives”) may give hope to desperate parents to have children. 
Yet, there is lot of difference between saving lives and giving life. Giving life carries 
social responsibility, which needs to take into account the child’s rights.
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